Vizhli Pharma Private Limited
About Vizhli Pharma Private Limited
Data last updated:
Vizhli Pharma Private Limited is a private limited company based in Namakkal, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U52310TZ2010PTC016390. Its GSTIN is 33AAJFV8593J1ZG (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Murugesan Sankarasubramanian and Sivakumar Venkataraman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4K Pillaiyar Koil Street, Namakkal, Tamil Nadu, India – 637001.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.65 Lakh. For the same year it recorded a net profit of ₹2.68 Lakh (net margin 4%) and EBITDA of ₹3.86 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Vizhli Pharma Private Limited's registered office is in Namakkal, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4K Pillaiyar Koil Street, Namakkal, Tamil Nadu, India – 637001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vizhli Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Vizhli Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vizhli Pharma Private Limited, buy the company report.
Financials of Vizhli Pharma Private Limited
FY 2025 filings availableVizhli Pharma Private Limited reported revenue of ₹67.65 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vizhli Pharma Private Limited, buy the company report.
Board of directors of Vizhli Pharma Private Limited
Vizhli Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murugesan Sankarasubramanian | Director | 22 Sep 2010 | 16 Years 1 Months | Current |
| Sivakumar Venkataraman | Director | 22 Sep 2010 | 16 Years 1 Months | Current |
| Ragupathy Appavu | Director | 22 Sep 2010 | 16 Years 1 Months | Current |
| Ramesh Palaniappan | Director | 22 Sep 2010 | 16 Years 1 Months | Current |
Peer comparison
Vizhli Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curific Lifesciences Private Limited | ₹67.99 Lakh (FY 2024) | 99.0% | Patna, Bihar, India | |||
| Richer and Swessary Chemicals Private Limited | ₹67.92 Lakh (FY 2025) | -2.0% | Bhopal, Madhya Pradesh, India | |||
| Cassel Research Laboratories Private Limited | ₹67.67 Lakh (FY 2023) | 180.0% | Chennai, Tamil Nadu, India | |||
| Vizhli Pharma Private Limitedthis company | ₹67.65 Lakh (FY 2025) | ₹2.68 Lakh | 4% | Namakkal, Tamil Nadu, India |
To see the full peer comparison of Vizhli Pharma Private Limited, buy the company report.
Auditor
Vizhli Pharma Private Limited is audited by TSSK & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TSSK & ASSOCIATES | FY 2017 | 014063S |
Shareholding
The shareholding of Vizhli Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vizhli Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vizhli Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vizhli Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vizhli Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAJFV8593J1ZG | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vizhli Pharma Private Limited, buy the company report.
Recent activity
Vizhli Pharma Private Limited has 4 board changes on record since 2010: 4 appointments. The latest: Murugesan Sankarasubramanian was appointed as Director on 22 Sep 2010.
Frequently asked questions
Vizhli Pharma is an active private limited company based in Namakkal, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 September 2010 (16+ years old) and is registered under CIN U52310TZ2010PTC016390.
Vizhli Pharma has 4 current directors:
- Murugesan Sankarasubramanian - Director
- Sivakumar Venkataraman - Director
- Ragupathy Appavu - Director
- Ramesh Palaniappan - Director
The latest financial statements of Vizhli Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vizhli Pharma is 33AAJFV8593J1ZG, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Vizhli Pharma is U52310TZ2010PTC016390. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vizhli Pharma was incorporated on 22 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Vizhli Pharma by revenue are Curific Lifesciences Private Limited, Richer and Swessary Chemicals Private Limited, Cassel Research Laboratories Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Murugesan Sankarasubramanian was appointed as Director on 22 Sep 2010. Ragupathy Appavu was appointed as Director on 22 Sep 2010. Ramesh Palaniappan was appointed as Director on 22 Sep 2010. Vizhli Pharma has 4 board changes on record in total.
The registered office of Vizhli Pharma is at 4K Pillaiyar Koil Street, Namakkal, Tamil Nadu, India – 637001.
Vizhli Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Vizhli Pharma is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
